drug

tecovirimat

1 story · latest Aug 6, 2026

Status: FDA approved Jul 2018 · NDA208627, NDA214518
Brand: Tpoxx
Code: ST-246
Trials: 7 registered trials in coverage

Relationships

Developed by SIGA Technologies

Also known as

tecovirimat monohydrate

Timeline

SIGA reports $37 million in TPOXX sales for second quarter of 2026

Aug 6Quarterly updateSIGA Technologies tecovirimat

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.